X
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.fiercepharma.com/pharma/biogen-pays-900m-resolve-ms-drugs-doctor-kickback-whistleblower-suit-competition-mounts
https://www.prnewswire.com/news-releases/abarca-details-first-value-based-agreement-for-medicaid-members-prescribed-biogen-products-301156036.html
https://www.prnewswire.com/news-releases/emd-serono-to-showcase-new-data-at-actrims-ectrims-msvirtual2020-meeting-furthering-innovation-in-multiple-sclerosis-301123847.html
https://www.reuters.com/article/us-health-coronavirus-eu-merck/merck-says-it-has-agreed-to-supply-potential-covid-19-drug-rebif-to-eu-countries-idUSKBN2492GM
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103780
https://www.prnewswire.com/news-releases/rebif-us-label-now-includes-pregnancy-outcomes-and-lactation-information-to-help-inform-treatment-decisions-for-women-with-ms-301066508.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125499
https://www.fiercepharma.com/pharma/merck-kgaa-donates-multiple-sclerosis-med-rebif-to-french-covid-19-trial
https://www.fiercepharma.com/pharma/merck-kgaa-donates-multiple-sclerosis-med-rebif-to-french-covid-19-trial
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103628
https://www.fiercepharma.com/pharma/biogen-beats-sales-estimates-but-analysts-stay-focused-alzheimer-s
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-16-2018-1526446624.pdf
https://endpts.com/bad-news-celgene-blasted-again-after-the-fda-kicks-back-their-marketing-application-on-blockbuster-hopeful-ozanimod/
https://www.fiercepharma.com/pharma/biogen-due-for-300m-windfall-from-new-year-s-price-hikes-analyst
http://www.pmlive.com/pharma_news/novartis_extavia_evades_nice_restrictions_on_ms_drugs_1214847
http://www.pharmafile.com/news/516087/nice-recommends-novartis-extavia-ms-knocks-back-raft-other-beta-interferons
http://www.biospectrumasia.com/news/26/8982/bayer-receives-fda-approval-of-mybetaapp-and-betaconnect-navigator.html
https://www.thestreet.com/story/13977435/1/biogen-reveals-federal-investigation-into-pricing-rebate-payments.html?cm_ven=RSSFeed
http://www.fiercepharma.com/pharma/biogen-joins-peers-federal-probe-patient-assistance-programs
http://www.prnewswire.com/news-releases/bayer-announces-fda-acceptance-of-supplemental-biologics-license-application-for-mybetaapp-and-betaconnect-navigator-300378185.html
http://www.prnewswire.com/news-releases/new-study-by-spherix-global-insights-indicates-high-therapy-switching-rates-for-multiple-sclerosis-patients-in-the-us-and-eu-benefitting-biogens-tecfidera-novartis-gilenya-and-sanofis-aubagio-300251625.html
http://www.prnewswire.com/news-releases/emd-serono-takes-on-exclusive-promotion-of-rebif-interferon-beta-1a-in-the-us-300205988.html
http://www.forbes.com/sites/johnlamattina/2016/01/05/promise-of-high-prices-now-driving-biopharma-r-d-investments/?ss=pharma-healthcare
http://www.fiercepharma.com/story/merck-kgaa-rolls-out-big-plans-expansion-africa/2015-11-20
https://www.bostonglobe.com/business/2015/11/11/biogen-tricky-transition-from-alzheimer/KSkCNxvxThdMIubVjejcfN/story.html
http://www.bloomberg.com/news/articles/2015-11-12/merck-kgaa-raises-forecast-after-quarterly-profit-beat-estimates
http://www.fiercepharma.com/story/merck-kgaa-counts-latin-america-power-consumer-health-future/2015-09-30
http://www.prnewswire.com/news-releases/new-rebif-interferon-beta-1a-data-at-ectrims-highlights-the-importance-of-disability-and-imaging-predictors-for-long-term-outcomes-300148524.html
http://www.bloomberg.com/news/articles/2015-04-24/health-the-price-of-multiple-sclerosis-drugs-only-goes-up
http://www.fiercepharma.com/story/mercks-rebif-held-its-own-last-years-ms-market-shakeup-what-about-2015/2015-03-03
http://www.pmlive.com/pharma_news/biogen_idec_plans_phase_iii_alzheimers_trial_before_year-end_640777
Market Place
Share 
